ÒÑÖªAPOE»ùÒòÊÇ°¢¶û´Äº£Ä¬²¡·¢²¡µÄΣº¦ÒòËØ£¬ÇÒÓëÂØ¿¨Ä¹µÈ¿¹¦Âµí·ÛÑùÂѰ׿¹ÌåÖÎÁÆÖеí·ÛÑùÂÑ°×Ïà¹ØÓ°ÏñѧÒì³££¨ARIA£©µÄ±¬·¢ÆµÂÊÏà¹Ø1¡£
ÔÚÈÕ±¾£¬ APOE»ùÒò¼ì²âÄ¿Ç°ÉÐδÄÉÈë¹úÃñ½¡¿µ°ü¹ÜµÄͨÀýÁÙ´²¹æ·¶¡£Òò´Ë£¬Í¨¹ýÀûÓá°AD-DMT×¢²á¹ÒºÅ¡±ÖÐÊÕ¼¯µÄAPOE»ùÒòÐÅÏ¢£¬ng28ÄϹ¬ºÍNCNP½«Äܹ»½øÒ»²½Ñо¿APOE»ùÒòÐÍÓëÂØ¿¨Ä¹ÖÎÁƵÄÄþ¾²ÐÔºÍÓÐЧÐÔÖ®¼äµÄ¹Øϵ¡£
ƾ¾ÝÓëÈÕ±¾¹úÁ¢Éñ¾Ò½ÁÆÑо¿ÖÐÐÄ£¨NCNP£©¸æ¿¢µÄÕâÏîÑо¿ÏàÖúÐÒ飬ng28ÄϹ¬½«µ£¸ºÔÚ¡°AD-DMT×¢²á¹ÒºÅ¡±ÖÐËùÐèµÄAPOE»ùÒò¼ì²âµÄÓöȡ£ÕâЩÑо¿½á¹û£¬Á¬Í¬´ÓÂØ¿¨Ä¹ÉÏÊкóÌض¨¼à²â£¨È«²¡Àý¼à²â£©ÖÐÊÕ¼¯µÄÊý¾Ý£¬½«³ÉΪÈÕ±¾Ò©Æ·ºÍÒ½ÁÆÆ÷еÖÎÀí¾Ö£¨PMDA£©¶ÔÂØ¿¨Ä¹ÉêÇë½øÐÐÔÙÉóÆÀµÄÒ»²¿·Ö£¬ÒÔÈ·±£ÆäÔÚ¸ÄÉÆ»¼ÕßÔ¤ºó·½ÃæÄܹ»·´Ó¦×îеĿÆѧÈÏʶ¡£
ng28ÄϹ¬ºÍ²³½¡ÈÕ±¾½«¼ÌÐøͨ¹ýÓëѧÊõ½çµÄÁ¬ÐøÏàÖú£¬Îª°¢¶û´Äº£Ä¬²¡ÖÎÁƵĽø²½×ö³öТ¾´¡£
ÂØ¿¨Ä¹µÄÈ«Çò¿ª·¢ºÍ×¢²áÉêÇëÓÉng28ÄϹ¬Ö÷µ¼£¬¶ø²úÆ·ÔòÓÉng28ÄϹ¬ºÍ²³½¡ÅäºÏÉÌÒµ»¯ºÍÍƹ㡣ÆäÖУ¬ng28ÄϹ¬ÓµÓÐ×îÖÕ¾ö²ßȨ¡£ÔÚÈÕ±¾£¬ng28ÄϹ¬ºÍ²³½¡ÈÕ±¾½«ÅäºÏÍƹã LEQEMBI£¬ng28ÄϹ¬½«×÷ΪӪÏúÊÚȨ³ÖÓÐÈË·ÖÏú¸Ã²úÆ·¡£
1.Foley KE and Wilcock DM (2024). Three major effects of APOE¦Å4 on A¦Â immunotherapy induced ARIA. Front. Aging Neurosci. 16:1412006. doi: 10.3389/fnagi.2024.1412006